Novartis Aktie
107,60
EUR
-3,35
EUR
-3,02
%
99,25
CHF
-3,91
CHF
-3,79
%
Werbung
Novartis Aktie Analyse
| 24.09.12 | Novartis reduce | Vontobel Research | |
| 24.09.12 | Novartis buy | Sarasin Research | |
| 13.09.12 | Novartis reduce | Vontobel Research | |
| 12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 11.09.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 11.09.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
|
Werbung
|
|||
| 05.09.12 | Novartis reduce | Vontobel Research | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.09.12 | Novartis reduce | Vontobel Research | |
| 03.09.12 | Novartis kaufen | Die Actien-Börse | |
| 31.08.12 | Novartis buy | Deutsche Bank AG | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis buy | Sarasin Research | |
| 30.08.12 | Novartis reduce | Vontobel Research | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
| 28.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Novartis reduce | Vontobel Research | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 16.08.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 15.08.12 | Novartis buy | Nomura | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis buy | Sarasin Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 17.07.12 | Novartis buy | Deutsche Bank AG | |
| 17.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 17.07.12 | Novartis buy | UBS AG | |
| 13.07.12 | Novartis buy | Nomura | |
| 13.07.12 | Novartis kaufen | Fuchsbriefe | |
| 12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Novartis outperform | Credit Suisse Group | |
| 12.07.12 | Novartis hold | Vontobel Research | |
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.07.12 | Novartis buy | Deutsche Bank AG | |
Werbung
Werbung